The French Competition Authority dismisses allegation of abuse against a pharmaceutical company (Sanofi-Aventis)

In a recently published decision of 14 January 2010, the French Competition Authority dismissed the allegation of the French Minister for the Economy against Sanofi-Aventis (“Sanofi”) concerning that firm’s pricing practices on the market for the supply of low-molecular-weight heparins (“LMWHs”) to hospitals. LMWHs are anticoagulants used to treat and prevent thrombosis. On 7 July 2006, the Minister for the Economy alleged that Sanofi‘s free supplies of LMWHs to hospitals for use in preventing thrombosis

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • Van Bael & Bellis (Brussels)
  • Practising Law Institute (New York)

Citation

Tim Kasten, Sean Gerlich, The French Competition Authority dismisses allegation of abuse against a pharmaceutical company (Sanofi-Aventis), 14 janvier 2010, e-Competitions January 2010, Art. N° 41645

Visites 281

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues